BCM
GILD icon

BBT Capital Management’s Gilead Sciences GILD Stock Holding History

BBT Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-75,000
Closed -$5.32M – 240
2014
Q1 		$5.32M Buy
+75,000
New +$5.88M 0.24% 104

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BBT Capital Management's GILD Position: Q2 2014 in Review

BBT Capital Management sold out of Gilead Sciences (GILD) in Q2 2014, closing a stake of 75,000 shares — an estimated $5.32M sold.

BBT Capital Management first reported a position in GILD in Q1 2014 and held it in 1 quarter. The position peaked at $5.32M in Q1 2014. 1,263 funds tracked by Wall St. Rank hold GILD as of Q2 2014.

  • BBT Capital Management reported no remaining Gilead Sciences position as of Q2 2014 after selling out during the quarter.
  • BBT Capital Management sold 75,000 Gilead Sciences shares in Q2 2014, an estimated $5.32M.
  • BBT Capital Management first reported a position in Gilead Sciences in Q1 2014 and held it in 1 quarter.
  • BBT Capital Management's Gilead Sciences position peaked at $5.32M in Q1 2014.
  • 1,263 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2014.

Based on BBT Capital Management's 13F filing for Q2 2014, filed 8 Aug 2014.